‡ In these countries please contact our distributor

Collagenase SANTYL

Ointment 250 units/gram

Collagenase SANTYL Ointment 250 units/gram


Collagenase SANTYL Ointment is the only enzymatic debrider approved by the FDA for use in the U.S. It selectively removes necrotic tissue without harming granulation tissue.

Collagenase SANTYL Ointment is indicated for debriding chronic dermal ulcers and severely burned areas.

Occasional slight transient erythema has been noted in surrounding tissue when applied outside the wound. One case of systemic hypersensitivity has been reported after 1 year of treatment with collagenase and cortisone. Use of Collagenase SANTYL Ointment should be terminated when debridement is complete and granulation tissue is well established.

Click here to review the SANTYL Motley Leave-Behind

For detailed HCP and Patient information, please visit the SANTYL website

This information is intended for health care professionals in the United States only.

Caution: US Federal law restricts the sale of these devices to or on the order of a physician.